However, its use beyond this approved indication, such as for erectile dysfunction in men, is considered off-label
Multifunctionality and Possible Medical Application of the BPC 157 Peptide Literature and Patent Review
Most recently, in 2021, the FDA approved a more potent dose of injectable Semaglutide, this time under the brand name Wegovy
For men, PT-141 may still be prescribed through specialized clinics (like Low T Center), but this is considered off-label use, meaning it hasnt been formally approved by the FDA for that specific purpose
10.1016/j.ccell.2016.03.004 86 QuW.ChenX.WangJ.LvJ.YanD
Insulin signaling, glucose metabolism and mitochondria: major players in Alzheimer's disease and diabetes interrelation